Medical new outlet: Suning Global 5 billion yuan layout medical beauty industry
Recently, Suning Global issued a number of announcements on investment mergers and acquisitions: 1 participation in South Korea ID Health Group and joint venture to establish a company in China; 2 issue of shares and cash to acquire 80% equity of Irmeigang Hospital; 3 joint venture with major shareholders to establish 5 billion Yuanmeimei Investment Fund; 4Medical and American Fund Strategic Investment “More Beautiful†APP; 5 Medical and Aesthetic Industry Fund acquired 11 medical and beauty hospitals and clinics for 570 million yuan, including 100% equity of four American United Hospitals, two Koreans 80% of Chenchen Hospital, 80% of Shanghai Port Hospital, and four clinics (Guangzhou Yuya 100%, Shanghai Port Longzhong Chinese Medicine 80%, Shanghai Gubei Yueli 80%, Shanghai Yuemei 80%).
Why is Suning Tesco to enter the medical and beauty industry?
(1) The medical beauty industry enters the fast lane of development and has a large market space.
The penetration rate of medical beauty is still at a low level in China. In 2014, this figure was about 1.2%. Compared with some parts of Japan, South Korea, the United States and Europe, the growth rate is relatively fast, especially in per capita control. In the case of a significant increase in income (at the end of 2015, the per capita disposable income of urban residents was about US$4,660, and the first-tier cities and some second-tier cities have exceeded US$5,000). According to historical experience, the compound annual growth rate of medical and aesthetic industries will increase by 3 percentage points to 16.7. %, became a trillion market in 2019.
Although the medical and aesthetic industry has a huge space for development in China, the industry is still in its infancy and the concentration is relatively low.
According to Jason, the vice president of Suning Global, Suning Global has entered the field of medical beauty at the right time: “Big health is becoming a new growth point for China’s economy, and there is a phenomenon of explosive growth. Since 2016, the more consumers The more rational, the word-of-mouth marketing has become a diversion trend. The integration of the medical and aesthetic industry is also accelerating, the low-standard institutions are being eliminated, the rational medical aesthetics concept is being formed, and the diversion of the online medical beauty platform will become a trend, the industry will The low degree of scattered concentration and the high degree of concentration of the norm."
(2) Suning's global layout “Medical Beauty†can match the scale of existing assets and form synergies with real estate and culture.
On the one hand, after years of development, Suning Global has grown into a regional leading company with assets of 25 billion yuan, annual revenue of over 7 billion yuan and net profit of nearly 1 billion yuan. The existing business structure is mainly based on real estate development, while the business is involved. Health, culture, finance and other fields. In the direction of strategic transformation “big style + big health + big financeâ€, stylistic media is relatively light asset industry, it is difficult to carry large-scale transformation; and medical beauty industry has huge market potential, and it is also capital-intensive industry, and company The existing scales are more matched.
On the other hand, the development of the medical beauty field will form synergies with other companies' businesses: 1 Suning Global's current main business is real estate development, which is faced with a large number of high-net-worth customers, the focus of this group on health and beauty. Relatively high, therefore, with the continuous development of the listed company's medical beauty business, the high-end customers originally accumulated by the real estate business will be able to further enjoy the high-quality medical beauty services provided by listed companies; 2 the consumption of medical beauty has certain resistance Periodically, facing the widest range of consumer customers, it is less affected by macroeconomic fluctuations and can complement and complement the existing real estate industry.
In addition, the rapid growth of real estate development business has laid a solid foundation for the company to expand into new business areas. Based on the advantages and resources of the real estate industry, it can seize high-quality regional offline stores and increase the number of medical beauty hospitals; US customers provide a variety of consumer financial services, while providing capital support for the company's development in the field of medical beauty; synergies between the various business segments can reduce the cost of diversion, improve the speed of gathering passengers, optimize management resources, and improve management efficiency.
The experience of Japan, South Korea and other countries shows that the medical plastic surgery and performing arts industry have a good synergy effect, and it is no exception in China.
Joining Korea ID Group is one of the core competitiveness of Suning Global's medical and aesthetic industry
(1) Participated in the Korea ID Health Group and established a joint venture company in China.
As we all know, the best resources for the current medical and aesthetic industry technology reputation are in South Korea. China's listed companies such as Evergrande and Langzi, which are planning to enter the medical and aesthetic industry, have allegedly chosen Korean companies as partners. Suning Global has also selected Korean companies, ID Health Industry Group, as partners. Therefore, the ID is the core competitiveness of Suning Global to enter the “medical beauty industryâ€.
ID Health Industry Group is NO.1 of Korea's medical and beauty industry, with the advantage of “technology + talentsâ€: As the largest health care group in Korea, its industrial layout includes ID medical beauty, cosmetics, stem cells, health testing, training, etc. The world's first-class industrial technology capabilities, Korea's top professional talent team, efficient global customer diversion and medical beauty marketing ability, is the first medical beauty brand of Hanmin; its ID medical cosmetic surgery hospital, with dean-level expert doctor 40 Yu Ming, more than 500 professional medical staff, the largest single-agent in Asia, with the most qualified medical staff in Korea, the most academic and technical expertise, more than 15 years of experience, the most comprehensive ISO standard certified plastic surgery Hospital; ID Medical Aesthetic Surgery Hospital has a professional department center and related patented technology. The medical technology and medical equipment of each center are world-class, with the world's most successful cases of jaw plastic surgery, and the world's first V-line, first surgery S3, V3 and other surgical programs and patented technology, the first level of academic and surgical integration in Asia.
Antineoplastic,Antineoplastic Agents,Natural Antineoplastic,Methotrexate Antineoplastic
NOUVASANT GROUP LTD. , https://www.nouvasant.com